Peptides DB
Research-centric peptide and protocol reference hub

Snap-8 record · updated 17h ago

Skin & aestheticsHealing & recoveryGrade B · human evidenceResearch use only
All 22 studiesJump to the evidenceCompare
What is Snap-8 used for?

Snap-8, a synthetic peptide, is often explored for its potential anti-aging and skin-rejuvenating properties, particularly in cosmetic applications. Research into its efficacy and mechanisms of action is ongoing, with a focus on its ability to reduce the appearance of fine lines and wrinkles.

How it works: Inhibition of muscle contractions

Primarily researched for · Skin & aestheticsRoute · Topical application

Development stage

where Snap-8 sits between preclinical work and regulatory approval
  1. 1Current
    Preclinical
    Animal / in-vitro work
  2. 2Not reached
    Phase 1
    Safety in humans
  3. 3Not reached
    Phase 2
    Efficacy signal
  4. 4Not reached
    Phase 3
    Confirmatory trials
  5. 5Not reached
    Approved
    Cleared by a regulator

Stage is inferred from the highest trial phase in the indexed corpus and 49 registered trials. It describes the research record, not a recommendation.

Identity
NameSnap-8
Chain length—
Molecular weight1,073.2 Da
FormulaC42H72N16O15S
Structure typeNot established
ClassAesthetic
Research levelPreclinical
Discovered byAdded before provenance tracking · 2025

Mass and formula from PubChem CID 71587832. No verified residue count for this compound.

Pharmacology
MechanismInhibition of muscle contractions
RouteTopical application
Half-life—
Time to peak—
Duration—
Extraction confidence0.70
Effect profile · 0–5
These seven scores are generated by the Librarian — an autonomous agent running GPT-4o over the indexed studies, trials and label data for this compound. No human assigns them and no community vote moves them. Last recomputed Aug 27, 2026. How this works →
Research stats
Total studies22
Human / animal / cellular11 / 8 / 1
Highest trial phasePreclinical
Years covered2010–2026
Latest study5d ago
Publication history
20102026
Research funding
162,817 NIH projects · $24.8M awarded · through FY2026
Public grants naming this compound. Funding is interest, not evidence.
Safety signals
FAERS reportsnone recorded
Serious AEs in animal work—
Community reports—
Positive —Neutral —Negative —
Records

Study register

22 rows · newest 12 shownOpen in the library →
StudyTypeYearSummary depth
Mechanisms of obesogenic adipocyte signaling in mouse 3T3-L1 cells in response to plasma from C57BL/6 mice exposed to traffic-generated emissions and high-fat diet.
FindingNot reported in abstract.
In vitro2026Full text read0.70
Remote realities: In-depth conversations on antimicrobial stewardship in remote Indigenous communities using a One Health approach.
FindingNot reported in abstract.
Human2026Full text read0.70
Tick-borne pathogens in dogs and their ticks in France: Molecular and serological evidence from a multicenter participatory study.
Finding165 ticks collected from 82 dogs.
Human2026Full text read0.80
Mapping the resistance landscape: A large-scale study of polymyxin-resistant pathogens circulating in low-and middle-income countries
FindingNot reported in abstract.
Human2026Full text read0.70
Cobalt-Based Drug Delivery to the Brain using Rapid Short-Pulses of Focused Ultrasound and Microbubbles reduces Aβ aggregation in 5XFAD mice
Finding60.5% reduction in Aβ plaque area.
Animal2026Full text read0.70
Correlates of protection against SARS-CoV-2 shedding in a controlled human infection study in immune-experienced participants
FindingNot reported in abstract.
Human2026Full text read0.80
Rotavirus-NSP5 interacts with and hijacks host ATP citrate lyase to viroplasms, enhancing lipid biosynthesis for facilitating rotavirus infection.
FindingNot reported in abstract.
Animal2026Full text read0.70
Chebulinic acid suppresses NF-κB/TSLP signaling axis via ACLY-mediated lipid metabolism reprogramming to ameliorate atopic dermatitis.
FindingNot reported in abstract.
Animal2026Full text read0.70
Quantitative risk assessment of avian influenza: A scoping review.
Finding34 eligible studies identified from January 2020 to March 2025.
review2026Full text read0.90
Targeted Long-Read sequencing provides functional validation of variants predicted to alter splicing
FindingNot reported in abstract.
Human2026Full text read0.70
The vaginal microbiota varies by self-identified ethnicity and HIV status throughout pregnancy and relates to preterm birth risk in a United Kingdom observational cohort
Finding18.2% PTB rate among Black PWLWH, n=55.
Human2026Full text read0.80
Gut microbial metabolism of Flutamide attenuates its therapeutic efficacy against prostate cancer.
FindingNot reported in abstract.
Animal2026Full text read0.70

What people are saying

anecdotal · not evidence

Unverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching Snap-8 will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.

Community collection has not run yet, so this is an empty shelf rather than a quiet one — nothing has been read, and no conclusion about how much Snap-8 is discussed should be drawn from it.

Articles mentioning Snap-8